| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/2001 | CA2397657A1 Farnesyl protein transferase inhibitor combinations with platinum compounds |
| 09/07/2001 | CA2397475A1 Farnesyl protein transferase inhibitor combinations with vinca alkaloids |
| 09/07/2001 | CA2397448A1 Farnesyl protein transferase inhibitor combinations with further anti-cancer agents |
| 09/07/2001 | CA2397446A1 Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents |
| 09/07/2001 | CA2397425A1 Farnesyl protein transferase inhibitor combinations with taxane compounds |
| 09/07/2001 | CA2397349A1 Farnesyl protein transferase inhibitor combinations with an her2 antibody |
| 09/07/2001 | CA2397256A1 Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives |
| 09/07/2001 | CA2397253A1 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| 09/07/2001 | CA2397240A1 Farnesyl protein transferase inhibitor combinations with camptothecin compounds |
| 09/07/2001 | CA2397165A1 Thienopyridine derivatives, their production and use |
| 09/07/2001 | CA2396504A1 Inhibitors of hepatitis c virus ns3 protease |
| 09/07/2001 | CA2374585A1 Antimicrobial sanitizing lotion with skin protection properties |
| 09/07/2001 | CA2372185A1 Novel pharmaceutical or dietetic mushroom-based compositions |
| 09/07/2001 | CA2339676A1 Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection |
| 09/06/2001 | US20010020170 Spinal implants, insertion instruments, and methods of use |
| 09/06/2001 | US20010020114 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/06/2001 | US20010020097 Treatment of Alzheimer's disease |
| 09/06/2001 | US20010020095 High affinity for D4 receptors; treatment of schizophrenia, other psychoses, anxiety disorders, depression, alcohol abuse, impulse control disorders, aggression |
| 09/06/2001 | US20010020083 Sulfiding/nitrosylating cyclodextrins to form coating for medical devices (tubes, catheters) |
| 09/06/2001 | US20010020043 Administering polyhydroxylated stilbene |
| 09/06/2001 | US20010020042 Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/06/2001 | US20010020041 Improve viability of sperm; mixture containing antioxidant |
| 09/06/2001 | US20010020040 Hyperforin derivatives, use thereof and formulations containing them |
| 09/06/2001 | US20010020039 Controlled release formulation of divalproex sodium |
| 09/06/2001 | US20010020038 Using 4-(((cyanoimino)-((1,2,2-trimethylpropyl)amino) methyl)amino)benzonitrile |
| 09/06/2001 | US20010020036 Synergistic mixtures |
| 09/06/2001 | US20010020034 Isothiazole derivatives useful as anticancer agents |
| 09/06/2001 | US20010020032 Olanzapine |
| 09/06/2001 | US20010020031 Compositions of optically pure (+) norcisapride |
| 09/06/2001 | US20010020029 New multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H- indazole-3-carboxamide hydrochloride |
| 09/06/2001 | US20010020028 Agents for treating neurodegenerative disorders |
| 09/06/2001 | US20010020027 Using 1-(4-(1-(4-fluorophenyl)-1H-indole-3-yl)-1-butyl spiro(isobenzofuran-1(3H,4-piperidine) |
| 09/06/2001 | US20010020025 Mixture of antiserotonine compound with laxative; therapy for constipation |
| 09/06/2001 | US20010020024 Opioid analgesics |
| 09/06/2001 | US20010020023 Mixture of pseudoephedrine and 2-(4-(diphenylmethyl)-1-piperazinyl)acetic acid |
| 09/06/2001 | US20010020022 2{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/06/2001 | US20010020020 Method for treating patients with macular degeneration by administering substituted sulfonyl indenyl acetic acids and alcohols |
| 09/06/2001 | US20010020018 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 09/06/2001 | US20010020016 Formulation |
| 09/06/2001 | US20010020015 Combination progestin oral contraceptive regimen |
| 09/06/2001 | US20010020014 Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/06/2001 | US20010020012 Administering ligands for growth horomne receptors |
| 09/06/2001 | US20010020009 Using plant extract |
| 09/06/2001 | US20010020008 Administering tagatose |
| 09/06/2001 | US20010020002 Androgen activity antagonists as therapies for anorexia, anorexia nervosa and disorders characterized by a pathologically underweight condition |
| 09/06/2001 | US20010019725 High speed mixing of drug and carrier |
| 09/06/2001 | US20010019724 Carotenoid formulations, comprising a mixture of beta-carotene, lycopene and lutein |
| 09/06/2001 | US20010019722 Multilayer; sustained release |
| 09/06/2001 | US20010019719 Intravesical drug delivery system |
| 09/06/2001 | US20010019717 Moisture retaining component and sesquiterpene alcohol for improving dry or sensitive skin |
| 09/06/2001 | US20010019716 Ability to enter mammalian cells and to survive within macrophages; vaccines to prevent infection by Mycobacterium tuberculosis, diagnostic assays |
| 09/06/2001 | DE10035735A1 Composition preventing hair loss contains a combination of biotin or caffeine as effective ingredient together with a 10-18C fatty acid or salt |
| 09/06/2001 | DE10010430A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-5-ethyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity |
| 09/06/2001 | DE10010426A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity |
| 09/06/2001 | DE10010067A1 New 2-phenyl-imidazo (5,1-f) (1,2,4) triazin-4-one derivatives, are phosphodiesterase inhibitors useful for treating cardiovascular, cerebrovascular or urogenital disorders |
| 09/06/2001 | DE10009423A1 Cosmetic or pharmaceutical preparation especially for treatment of cellulite comprises nerve fibre stimulator or depolariser, phosphodiesterase inhibitor and antiestrogen |
| 09/06/2001 | DE10008522A1 Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen Use of 2-phenylenediamine for the treatment of infections |
| 09/06/2001 | DE10008159A1 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure (2-MTDC) und /oder ihrer physiologisch verträglichen Salze zur Behandlung und/oder Prophylaxe von Krebserkrankungen Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid (2-MTCD) and / or their physiologically tolerable salts for the treatment and / or prophylaxis of cancer |
| 09/06/2001 | DE10006889A1 Verwendung von Inhibitoren von Caspase-3 oder der Caspase-aktivierten Desoxyribonuclease (CAD) zur Behandlung von Herzerkrankungen Use of inhibitors of caspase-3 or caspase-activated deoxyribonuclease (CAD) for the treatment of heart disease |
| 09/06/2001 | CA2339051A1 Ketolide antibiotics |
| 09/05/2001 | EP1130122A2 Methods for the diagnosis of polymorphisms in the human EP1-R gene |
| 09/05/2001 | EP1130103A2 Nucleic acid from Tetrahymena coding for a trieterpenoid-cyclase, its production and use |
| 09/05/2001 | EP1130020A1 Tropane-derivatives, their preparation and use |
| 09/05/2001 | EP1130019A1 2,4-bis((4-Amidino)phenyl)furans as anti-pneumocystis carinii agents |
| 09/05/2001 | EP1130017A2 Azole derivatives and their use as superoxide radical inhibitors |
| 09/05/2001 | EP1130016A1 Thiocarbamic acid derivatives |
| 09/05/2001 | EP1129714A1 Use of tiludronic acid and its derivatives in poultry for the preparation of a medicine for preventing and treating osteoporosis |
| 09/05/2001 | EP1129713A1 Veterinary compositions for the treatment of parasitic diseases |
| 09/05/2001 | EP1129712A1 Quinolinone derivative preparations and process for producing the same |
| 09/05/2001 | EP1129711A2 Pinolenic acid against diabetes |
| 09/05/2001 | EP1129710A2 Method for treating migraine symptoms with ibuprofen and salts thereof |
| 09/05/2001 | EP1129709A2 Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof |
| 09/05/2001 | EP1129708A1 Use of sertraline to treat social phobia |
| 09/05/2001 | EP1129707A2 Methods for identifying and treating resistant tumors |
| 09/05/2001 | EP1129706A2 Use of cGMP PDE5 inhibitors for the treatment of neuropathy |
| 09/05/2001 | EP1129705A1 Powder formulation for inhalation |
| 09/05/2001 | EP1129699A1 Topical compositions containing whey protein |
| 09/05/2001 | EP1129697A1 Composition, particularly for cosmetics comprising a pentacyclic triterpene acid |
| 09/05/2001 | EP1129695A1 Cosmetic or dermatological sunscreen formulations |
| 09/05/2001 | EP1129694A1 Use of components for modifying physico-chemical properties of the skin and/or the mucosal tissue as adhesion prevention/decreasing adhesion agents for microorganisms |
| 09/05/2001 | EP1129693A2 Composition for inhibiting body odor and uses thereof |
| 09/05/2001 | EP1129683A1 Hyaluronic acid gel, process for the preparation thereof and medical materials containing the same |
| 09/05/2001 | EP1129350A1 Methods for identifying modulators of bs69 activity |
| 09/05/2001 | EP1129217A2 Compositions and methods of disease diagnosis and therapy |
| 09/05/2001 | EP1129212A1 Screening process for antibacterial agents |
| 09/05/2001 | EP1129208A1 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 09/05/2001 | EP1129199A2 Cell signaling polypeptides and nucleic acids |
| 09/05/2001 | EP1129183A2 Human glycine transporter type 2 |
| 09/05/2001 | EP1129177A1 Avipox vector coding an hiv antigen and a cytokine |
| 09/05/2001 | EP1129112A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/05/2001 | EP1129110A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 09/05/2001 | EP1129097A1 Novel type condensed pyridazinone compounds |
| 09/05/2001 | EP1129096A2 Crf receptor antagonists and methods relating thereto |
| 09/05/2001 | EP1129094A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 09/05/2001 | EP1129093A1 Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 09/05/2001 | EP1129091A2 Crf receptor antagonists and methods relating thereto |
| 09/05/2001 | EP1129090A1 PENTAAZA-CYCLOPENTA A]NAPHTHALENE DERIVATIVES AS LIGANDS FOR GABA A? $g(a)5 RECEPTORS |
| 09/05/2001 | EP1129089A1 Spiro-indolines as y5 receptor antagonists |